Global Dysphagia Management

Dysphagia Management Comprehensive Study by Type (High (Oropharangeal) Dysphagia, Low (Esophageal) Dysphagia), Application (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Specialty Clinics) Players and Region - Global Market Outlook to 2028

Dysphagia Management Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dysphagia Management
Dysphagia is a condition in which it is difficult to swallow food or liquids. Large bits of food, little chewing, dry mouth, medicines, or the eating of extremely hot food are all causes of the condition. Food texture changing items and other items, such as tubes, are used to help people with dysphagia swallow more easily. Although some medications are available to treat dysphagia, they are not effective for all types of illnesses. Dysphagia is becoming more common as the prevalence of various malignancies, particularly oral cancer, rises. Furthermore, several cancer treatments may create swallowing difficulties as a side effect, necessitating enhanced dysphagia control in order to avoid future issues. Because of the devastating consequences of choking, dysphagia management has become critical in both the geriatric and juvenile populations. Proton pump inhibitors, feeding tubes, and nutritional solutions such as thickeners and beverages are just a few of the dysphagia management options available. The appropriate dysphagia management option is determined by the severity of the condition.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


This overview provides a general understanding of the competitive landscape in Dysphagia Management. The specific needs of each individual will vary, and seeking professional medical guidance is essential for proper diagnosis, management, and support. Analyst at AMA Research estimates that European Players will contribute the maximum growth to Global Dysphagia Management market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Eisai Co. Ltd. (Japan), BectonDickinson and Company (United States), AstraZeneca Plc. (United Kingdom), Cipla Limited (India), Nestlé (Nestlé Health Science) (Switzerland), Nutricia Ltd (United Kingdom), Bracco S.p.A. (Italy), Phagenesis Ltd. (United Kingdom), Hormel Health Labs (United States) and Cook Medical Inc (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Thomsen Medical (Denmark), Lecico Nutrition (France), Nutricia (Netherlands) and Nihon Kohden Corporation (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Dysphagia Management market by Type (High (Oropharangeal) Dysphagia and Low (Esophageal) Dysphagia), Application (Hospital Pharmacies, Retail Pharmacies, Drug Stores and Specialty Clinics) and Region.



On the basis of geography, the market of Dysphagia Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increased Investment in Healthcare Industry

Market Growth Drivers:
Increasing Prevalence of Various Cancers, Especially Oral Cancer, Increases The Problem Of Dysphagia and Increasing Number of Geriatric Population

Challenges:
Difficulty in Diagnosis of The Exact Cause of Dysphagia and Lack of Advanced Therapies for Dysphagia

Restraints:
Side Effects and Discomfort of Dysphagia Drugs and High Cost of Treatment

Opportunities:
Improvement in Healthcare and Medical Services, and the Increasing Number of Specialty Clinics

Market Leaders and their expansionary development strategies
In October 2023, Medtronic partners with patient advocacy groups this collaboration focuses on educating patients about dysphagia and the benefits of Medtronic's Enteral Feeding System, empowering them to make informed decisions about their care.
In September 2023, Medtronic Enteral Feeding System with SmartSet Technology. This innovative feeding tube system features sensors and AI algorithms that automatically adjust feeding rates based on individual patient needs, potentially reducing complications and improving safety.


Key Target Audience
Drug Companies, Medical Device Companies, Investors, Medical Research Companies and Governmental bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • High (Oropharangeal) Dysphagia
  • Low (Esophageal) Dysphagia
By Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Specialty Clinics
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Various Cancers, Especially Oral Cancer, Increases The Problem Of Dysphagia
      • 3.2.2. Increasing Number of Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Difficulty in Diagnosis of The Exact Cause of Dysphagia
      • 3.3.2. Lack of Advanced Therapies for Dysphagia
    • 3.4. Market Trends
      • 3.4.1. Increased Investment in Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dysphagia Management, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dysphagia Management (Value)
      • 5.2.1. Global Dysphagia Management by: Type (Value)
        • 5.2.1.1. High (Oropharangeal) Dysphagia
        • 5.2.1.2. Low (Esophageal) Dysphagia
      • 5.2.2. Global Dysphagia Management by: Application (Value)
        • 5.2.2.1. Hospital Pharmacies
        • 5.2.2.2. Retail Pharmacies
        • 5.2.2.3. Drug Stores
        • 5.2.2.4. Specialty Clinics
      • 5.2.3. Global Dysphagia Management Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Dysphagia Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eisai Co. Ltd. (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BectonDickinson and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AstraZeneca Plc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cipla Limited (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Nestlé (Nestlé Health Science) (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Nutricia Ltd (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bracco S.p.A. (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Phagenesis Ltd. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hormel Health Labs (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cook Medical Inc (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Dysphagia Management Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Dysphagia Management (Value)
      • 7.2.1. Global Dysphagia Management by: Type (Value)
        • 7.2.1.1. High (Oropharangeal) Dysphagia
        • 7.2.1.2. Low (Esophageal) Dysphagia
      • 7.2.2. Global Dysphagia Management by: Application (Value)
        • 7.2.2.1. Hospital Pharmacies
        • 7.2.2.2. Retail Pharmacies
        • 7.2.2.3. Drug Stores
        • 7.2.2.4. Specialty Clinics
      • 7.2.3. Global Dysphagia Management Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dysphagia Management: by Type(USD Million)
  • Table 2. Dysphagia Management High (Oropharangeal) Dysphagia , by Region USD Million (2017-2022)
  • Table 3. Dysphagia Management Low (Esophageal) Dysphagia , by Region USD Million (2017-2022)
  • Table 4. Dysphagia Management: by Application(USD Million)
  • Table 5. Dysphagia Management Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 6. Dysphagia Management Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 7. Dysphagia Management Drug Stores , by Region USD Million (2017-2022)
  • Table 8. Dysphagia Management Specialty Clinics , by Region USD Million (2017-2022)
  • Table 9. South America Dysphagia Management, by Country USD Million (2017-2022)
  • Table 10. South America Dysphagia Management, by Type USD Million (2017-2022)
  • Table 11. South America Dysphagia Management, by Application USD Million (2017-2022)
  • Table 12. Brazil Dysphagia Management, by Type USD Million (2017-2022)
  • Table 13. Brazil Dysphagia Management, by Application USD Million (2017-2022)
  • Table 14. Argentina Dysphagia Management, by Type USD Million (2017-2022)
  • Table 15. Argentina Dysphagia Management, by Application USD Million (2017-2022)
  • Table 16. Rest of South America Dysphagia Management, by Type USD Million (2017-2022)
  • Table 17. Rest of South America Dysphagia Management, by Application USD Million (2017-2022)
  • Table 18. Asia Pacific Dysphagia Management, by Country USD Million (2017-2022)
  • Table 19. Asia Pacific Dysphagia Management, by Type USD Million (2017-2022)
  • Table 20. Asia Pacific Dysphagia Management, by Application USD Million (2017-2022)
  • Table 21. China Dysphagia Management, by Type USD Million (2017-2022)
  • Table 22. China Dysphagia Management, by Application USD Million (2017-2022)
  • Table 23. Japan Dysphagia Management, by Type USD Million (2017-2022)
  • Table 24. Japan Dysphagia Management, by Application USD Million (2017-2022)
  • Table 25. India Dysphagia Management, by Type USD Million (2017-2022)
  • Table 26. India Dysphagia Management, by Application USD Million (2017-2022)
  • Table 27. South Korea Dysphagia Management, by Type USD Million (2017-2022)
  • Table 28. South Korea Dysphagia Management, by Application USD Million (2017-2022)
  • Table 29. Taiwan Dysphagia Management, by Type USD Million (2017-2022)
  • Table 30. Taiwan Dysphagia Management, by Application USD Million (2017-2022)
  • Table 31. Australia Dysphagia Management, by Type USD Million (2017-2022)
  • Table 32. Australia Dysphagia Management, by Application USD Million (2017-2022)
  • Table 33. Rest of Asia-Pacific Dysphagia Management, by Type USD Million (2017-2022)
  • Table 34. Rest of Asia-Pacific Dysphagia Management, by Application USD Million (2017-2022)
  • Table 35. Europe Dysphagia Management, by Country USD Million (2017-2022)
  • Table 36. Europe Dysphagia Management, by Type USD Million (2017-2022)
  • Table 37. Europe Dysphagia Management, by Application USD Million (2017-2022)
  • Table 38. Germany Dysphagia Management, by Type USD Million (2017-2022)
  • Table 39. Germany Dysphagia Management, by Application USD Million (2017-2022)
  • Table 40. France Dysphagia Management, by Type USD Million (2017-2022)
  • Table 41. France Dysphagia Management, by Application USD Million (2017-2022)
  • Table 42. Italy Dysphagia Management, by Type USD Million (2017-2022)
  • Table 43. Italy Dysphagia Management, by Application USD Million (2017-2022)
  • Table 44. United Kingdom Dysphagia Management, by Type USD Million (2017-2022)
  • Table 45. United Kingdom Dysphagia Management, by Application USD Million (2017-2022)
  • Table 46. Netherlands Dysphagia Management, by Type USD Million (2017-2022)
  • Table 47. Netherlands Dysphagia Management, by Application USD Million (2017-2022)
  • Table 48. Rest of Europe Dysphagia Management, by Type USD Million (2017-2022)
  • Table 49. Rest of Europe Dysphagia Management, by Application USD Million (2017-2022)
  • Table 50. MEA Dysphagia Management, by Country USD Million (2017-2022)
  • Table 51. MEA Dysphagia Management, by Type USD Million (2017-2022)
  • Table 52. MEA Dysphagia Management, by Application USD Million (2017-2022)
  • Table 53. Middle East Dysphagia Management, by Type USD Million (2017-2022)
  • Table 54. Middle East Dysphagia Management, by Application USD Million (2017-2022)
  • Table 55. Africa Dysphagia Management, by Type USD Million (2017-2022)
  • Table 56. Africa Dysphagia Management, by Application USD Million (2017-2022)
  • Table 57. North America Dysphagia Management, by Country USD Million (2017-2022)
  • Table 58. North America Dysphagia Management, by Type USD Million (2017-2022)
  • Table 59. North America Dysphagia Management, by Application USD Million (2017-2022)
  • Table 60. United States Dysphagia Management, by Type USD Million (2017-2022)
  • Table 61. United States Dysphagia Management, by Application USD Million (2017-2022)
  • Table 62. Canada Dysphagia Management, by Type USD Million (2017-2022)
  • Table 63. Canada Dysphagia Management, by Application USD Million (2017-2022)
  • Table 64. Mexico Dysphagia Management, by Type USD Million (2017-2022)
  • Table 65. Mexico Dysphagia Management, by Application USD Million (2017-2022)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Dysphagia Management: by Type(USD Million)
  • Table 77. Dysphagia Management High (Oropharangeal) Dysphagia , by Region USD Million (2023-2028)
  • Table 78. Dysphagia Management Low (Esophageal) Dysphagia , by Region USD Million (2023-2028)
  • Table 79. Dysphagia Management: by Application(USD Million)
  • Table 80. Dysphagia Management Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 81. Dysphagia Management Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 82. Dysphagia Management Drug Stores , by Region USD Million (2023-2028)
  • Table 83. Dysphagia Management Specialty Clinics , by Region USD Million (2023-2028)
  • Table 84. South America Dysphagia Management, by Country USD Million (2023-2028)
  • Table 85. South America Dysphagia Management, by Type USD Million (2023-2028)
  • Table 86. South America Dysphagia Management, by Application USD Million (2023-2028)
  • Table 87. Brazil Dysphagia Management, by Type USD Million (2023-2028)
  • Table 88. Brazil Dysphagia Management, by Application USD Million (2023-2028)
  • Table 89. Argentina Dysphagia Management, by Type USD Million (2023-2028)
  • Table 90. Argentina Dysphagia Management, by Application USD Million (2023-2028)
  • Table 91. Rest of South America Dysphagia Management, by Type USD Million (2023-2028)
  • Table 92. Rest of South America Dysphagia Management, by Application USD Million (2023-2028)
  • Table 93. Asia Pacific Dysphagia Management, by Country USD Million (2023-2028)
  • Table 94. Asia Pacific Dysphagia Management, by Type USD Million (2023-2028)
  • Table 95. Asia Pacific Dysphagia Management, by Application USD Million (2023-2028)
  • Table 96. China Dysphagia Management, by Type USD Million (2023-2028)
  • Table 97. China Dysphagia Management, by Application USD Million (2023-2028)
  • Table 98. Japan Dysphagia Management, by Type USD Million (2023-2028)
  • Table 99. Japan Dysphagia Management, by Application USD Million (2023-2028)
  • Table 100. India Dysphagia Management, by Type USD Million (2023-2028)
  • Table 101. India Dysphagia Management, by Application USD Million (2023-2028)
  • Table 102. South Korea Dysphagia Management, by Type USD Million (2023-2028)
  • Table 103. South Korea Dysphagia Management, by Application USD Million (2023-2028)
  • Table 104. Taiwan Dysphagia Management, by Type USD Million (2023-2028)
  • Table 105. Taiwan Dysphagia Management, by Application USD Million (2023-2028)
  • Table 106. Australia Dysphagia Management, by Type USD Million (2023-2028)
  • Table 107. Australia Dysphagia Management, by Application USD Million (2023-2028)
  • Table 108. Rest of Asia-Pacific Dysphagia Management, by Type USD Million (2023-2028)
  • Table 109. Rest of Asia-Pacific Dysphagia Management, by Application USD Million (2023-2028)
  • Table 110. Europe Dysphagia Management, by Country USD Million (2023-2028)
  • Table 111. Europe Dysphagia Management, by Type USD Million (2023-2028)
  • Table 112. Europe Dysphagia Management, by Application USD Million (2023-2028)
  • Table 113. Germany Dysphagia Management, by Type USD Million (2023-2028)
  • Table 114. Germany Dysphagia Management, by Application USD Million (2023-2028)
  • Table 115. France Dysphagia Management, by Type USD Million (2023-2028)
  • Table 116. France Dysphagia Management, by Application USD Million (2023-2028)
  • Table 117. Italy Dysphagia Management, by Type USD Million (2023-2028)
  • Table 118. Italy Dysphagia Management, by Application USD Million (2023-2028)
  • Table 119. United Kingdom Dysphagia Management, by Type USD Million (2023-2028)
  • Table 120. United Kingdom Dysphagia Management, by Application USD Million (2023-2028)
  • Table 121. Netherlands Dysphagia Management, by Type USD Million (2023-2028)
  • Table 122. Netherlands Dysphagia Management, by Application USD Million (2023-2028)
  • Table 123. Rest of Europe Dysphagia Management, by Type USD Million (2023-2028)
  • Table 124. Rest of Europe Dysphagia Management, by Application USD Million (2023-2028)
  • Table 125. MEA Dysphagia Management, by Country USD Million (2023-2028)
  • Table 126. MEA Dysphagia Management, by Type USD Million (2023-2028)
  • Table 127. MEA Dysphagia Management, by Application USD Million (2023-2028)
  • Table 128. Middle East Dysphagia Management, by Type USD Million (2023-2028)
  • Table 129. Middle East Dysphagia Management, by Application USD Million (2023-2028)
  • Table 130. Africa Dysphagia Management, by Type USD Million (2023-2028)
  • Table 131. Africa Dysphagia Management, by Application USD Million (2023-2028)
  • Table 132. North America Dysphagia Management, by Country USD Million (2023-2028)
  • Table 133. North America Dysphagia Management, by Type USD Million (2023-2028)
  • Table 134. North America Dysphagia Management, by Application USD Million (2023-2028)
  • Table 135. United States Dysphagia Management, by Type USD Million (2023-2028)
  • Table 136. United States Dysphagia Management, by Application USD Million (2023-2028)
  • Table 137. Canada Dysphagia Management, by Type USD Million (2023-2028)
  • Table 138. Canada Dysphagia Management, by Application USD Million (2023-2028)
  • Table 139. Mexico Dysphagia Management, by Type USD Million (2023-2028)
  • Table 140. Mexico Dysphagia Management, by Application USD Million (2023-2028)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dysphagia Management: by Type USD Million (2017-2022)
  • Figure 5. Global Dysphagia Management: by Application USD Million (2017-2022)
  • Figure 6. South America Dysphagia Management Share (%), by Country
  • Figure 7. Asia Pacific Dysphagia Management Share (%), by Country
  • Figure 8. Europe Dysphagia Management Share (%), by Country
  • Figure 9. MEA Dysphagia Management Share (%), by Country
  • Figure 10. North America Dysphagia Management Share (%), by Country
  • Figure 11. Global Dysphagia Management share by Players 2022 (%)
  • Figure 12. Global Dysphagia Management share by Players (Top 3) 2022(%)
  • Figure 13. Global Dysphagia Management share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Eisai Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 16. Eisai Co. Ltd. (Japan) Revenue: by Geography 2022
  • Figure 17. BectonDickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 18. BectonDickinson and Company (United States) Revenue: by Geography 2022
  • Figure 19. AstraZeneca Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. AstraZeneca Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 21. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 22. Cipla Limited (India) Revenue: by Geography 2022
  • Figure 23. Nestlé (Nestlé Health Science) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Nestlé (Nestlé Health Science) (Switzerland) Revenue: by Geography 2022
  • Figure 25. Nutricia Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. Nutricia Ltd (United Kingdom) Revenue: by Geography 2022
  • Figure 27. Bracco S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 28. Bracco S.p.A. (Italy) Revenue: by Geography 2022
  • Figure 29. Phagenesis Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Phagenesis Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 31. Hormel Health Labs (United States) Revenue, Net Income and Gross profit
  • Figure 32. Hormel Health Labs (United States) Revenue: by Geography 2022
  • Figure 33. Cook Medical Inc (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cook Medical Inc (United States) Revenue: by Geography 2022
  • Figure 35. Global Dysphagia Management: by Type USD Million (2023-2028)
  • Figure 36. Global Dysphagia Management: by Application USD Million (2023-2028)
  • Figure 37. South America Dysphagia Management Share (%), by Country
  • Figure 38. Asia Pacific Dysphagia Management Share (%), by Country
  • Figure 39. Europe Dysphagia Management Share (%), by Country
  • Figure 40. MEA Dysphagia Management Share (%), by Country
  • Figure 41. North America Dysphagia Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eisai Co. Ltd. (Japan)
  • BectonDickinson and Company (United States)
  • AstraZeneca Plc. (United Kingdom)
  • Cipla Limited (India)
  • Nestlé (Nestlé Health Science) (Switzerland)
  • Nutricia Ltd (United Kingdom)
  • Bracco S.p.A. (Italy)
  • Phagenesis Ltd. (United Kingdom)
  • Hormel Health Labs (United States)
  • Cook Medical Inc (United States)
Additional players considered in the study are as follows:
Thomsen Medical (Denmark) , Lecico Nutrition (France) , Nutricia (Netherlands) , Nihon Kohden Corporation (Japan)
Select User Access Type

Key Highlights of Report


Dec 2023 200 Pages 96 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dysphagia Management Quantitative research analysis
Global Dysphagia Management Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Eisai Co. Ltd. (Japan), BectonDickinson and Company (United States), AstraZeneca Plc. (United Kingdom), Cipla Limited (India), Nestlé (Nestlé Health Science) (Switzerland), Nutricia Ltd (United Kingdom), Bracco S.p.A. (Italy), Phagenesis Ltd. (United Kingdom), Hormel Health Labs (United States) and Cook Medical Inc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increased Investment in Healthcare Industry" is seen as one of major influencing trends for Dysphagia Management Market during projected period 2022-2028.
The Dysphagia Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dysphagia Management Report?

Have a Query? Click Here

Other Related Reports

Combination Antibody Therapy Comprehensive Study by Type (Chemotherapy/Antibody, Antibody/Antibody, Conjugated Antibodies, Bispecific Antibodies), Application (Lung Cancer, Blood Cancer (Lymphoma, Le...
$ 3650
Carcinoid Syndrome Diarrhea Treatment Comprehensive Study by End User (Hospitals and Clinics, Cancer Research Institutes, Others), Treatment (Chemotherapy, Oral Therapy, Somatostatin Analog (SSA) Th...
$ 3500
Cytomegalovirus Infection Comprehensive Study by Type (Cidofovir, Foscarnet, Valganciclovir, Ganciclovir), Application (Hospitals, Retail Pharmacies, Online Pharmacies), Infection (Retinitis, Pneumon...
$ 3750
Brain Disease Comprehensive Study by Disease Type (Neurodegenerative Diseases, Neurovascular Diseases, Mental Disorders, Traumatic Brain Injuries), Distribution Channel (Hospitals Pharmacy, Online Ph...
$ 3750
Plasma Fractionation Comprehensive Study by Type (Immunoglobulins, Coagulation Factor Concentrates, Albumin, Protease Inhibitors, Others), Application (Immunology, Hematology, Neurology, Others), End...
$ 3750
Endometriosis Therapies Comprehensive Study by Type (Hormonal Therapy (Oral Contraceptive Pills, Progestins), Hormone Replacement Therapy (GnRH Agonists, Luteinizing-hormone-releasing hormone recepto...
$ 3750